Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | CRGE | Common Stock | 150K | Apr 11, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CRGE | Options, right to buy | Apr 11, 2022 | Common Stock | 200K | $3.20 | Direct | F1 | ||||||
holding | CRGE | Options, right to buy | Apr 11, 2022 | Common Stock | 1.25M | $3.00 | Direct | F2 |
Id | Content |
---|---|
F1 | On August 17, 2021, the Reporting Person was granted options to purchase 200,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Plan. The options shall vest annually in four equal installments, beginning on August 17, 2022. The options are exercisable for a term of six years. |
F2 | On October 28, 2021, the Reporting Person was granted options to purchase 1,250,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Plan. The options shall vest annually in four equal installments, beginning on October 28, 2022. The options are exercisable for a term of five years. |